The following letter to the HISA board was signed by trainers W.I. Mott, Chad Brown, Mark Casse, Jena Antonucci, and Ron Moquett; and Eric Hamelback, CEO of the National Horsemen's Benevolent & ...
The British Horseracing Authority issued a notice to horsemen that three paste-form products marketed as equine supplements had been found to contain banned substances; two of the three are available ...
Lung lesions; slaughtered horses; Brazil; equine multinodular pulmonary fibrosis; granulomatous eosinophilic pneumonia; pneumonia; pythiosis; recurrent airway obstruction; Streptococcus equi; horses; ...
Chronic obstructive pulmonary disease, or COPD, is an ongoing group of lung conditions that include chronic bronchitis and emphysema. COPD is the result of damaged lung tissue, which leads to ...
Mona Bafadhel receives funding from the National Institute of Health Research, Asthma+Lung UK, and Horizon Europe. For this study, Mona Bafadhel received funding from AstraZeneca to complete the study ...
A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave the way for new treatment options. We live longer and longer, and as we age ...
ABSTRACT: Cardiac arrhythmias are probably more common in horses than in any other domestic animal species where poor performance and exercise intolerance is the most frequent clinical complaint.
Horses are fascinating and deeply emotional beings. I often think of them as the definition of sentience—the ability to feel. In my limited close interactions with horses, I could feel their presence ...
After more than a decade without any therapeutic advancements in chronic obstructive pulmonary disorder (COPD), people with the progressive disease suddenly have two new options, with more likely on ...
The protease inhibitor system (PI) was investigated to ascertain if it can be used as a marker of chronic obstructive pulmonary disease (COPD) in thoroughbred horses. Serum samples were taken from ...
GSK is heading into the weekend with a win for its respiratory blockbuster Nucala—but for now, the details are slim. On Friday, GSK said that its IL-5 antibody Nucala plus inhaled maintenance therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results